The Health Ministry has announced that Vietnam will have more than 120 million COVID-19 vaccine doses in 2021.
VOV.VN - Organisations and individuals have so far committed more than VND5.6 trillion to the national COVID-19 vaccine fund since it was established not long ago to support the national vaccination campaign.
Representatives of international organisations in Vietnam have spoken highly of the solidarity and sense of responsibility amongst the people in the COVID-19 fight through the vaccine fund initiative.
Leaders or representatives of religious organisations will be held accountable if their places of worship fail to follow COVID-19 prevention and control rules resulting in virus transmission among dignitaries, followers, and the community, according to the Committee for Religious Affairs.
A virtual race is underway to raise money for Vietnam’s COVID-19 vaccine fund, with the message “Steps for Solidarity”, according to the Vietnam Sports Administration.
VOV.VN - The Ministry of Health on June 6 morning reported the latest detection of a further 39 locally-transmitted cases, with the majority found in Bac Giang at 21, Ho Chi Minh City at 10 and Bac Ninh at 8, thereby lifting the overall number of infections in Vietnam to 7,029.
VOV.VN - A COVID-19 vaccine fund made its debut on June 5 evening in Hanoi, featuring the participation of Prime Minister Pham Minh Chinh, officials from the Vietnam Fatherland Front, ministries, sectors, and socio-political organisations, business community representatives and others.
VOV.VN - An additional 83 novel coronavirus (COVID-19) cases were reported on June 5 evening, thereby raising the national daily tally to 246, according to data released by the Health Ministry.
VOV.VN - Russia is set to discuss cooperation in COVID-19 vaccine Sputnik-V production with Vietnam, Press Secretary for the Russian President Dmitry Peskov told the media recently.
The clinical trials of Vietnamese COVID-19 vaccine candidate Nano Covax are set to enter Phase 3 this month with the optimal dosage of 25mcg, aiming to further test the safety and efficacy of the vaccine in humans before mass production begins.